close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
99 100 Next >
Johnson & Johnson's Uninterrupted Dividend Growth: Innovation in Medicine and MedTech Drives Strong Q2 2025 Performance
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
Tickers ABBV AMGN BMY BSX ISRG JNJ
Exposures Artificial Intelligence Intellectual Property Product Safety
Eli Lilly's Ascent: A New Era in Obesity Treatment Driven by Zepbound and Orforglipron
Via MarketMinute
Topics Economy
Tickers AMGN LLY NVO
Exposures Product Safety Supply Chain
IBD 50's Tempus AI Hits Record High On Yet Another FDA Clearance
Via Investor's Business Daily
Topics Artificial Intelligence Intellectual Property
Tickers PFE TEM
Exposures Artificial Intelligence Intellectual Property Product Safety
Ford Recalls Over 100,000 Taurus Vehicles In US Over Concerns Of Detaching Door Trims
Via Stocktwits
Topics Product Recall
Tickers AVUS F SPXV
Exposures Legal Product Safety
Shareholders That Lost Money on Cytokinetics, Incorporated (CYTK) Should Contact Levi & Korsinsky About Pending Class Action - CYTK
Via NewMediaWire
Topics Earnings Fraud Lawsuit
Tickers CYTK
Exposures Financial Legal Product Safety
Levi & Korsinsky Notifies Shareholders of Savara Inc. (SVRA) of a Class Action Lawsuit and an Upcoming Deadline
Via NewMediaWire
Topics Fraud Lawsuit
Tickers SVRA
Exposures Financial Legal Product Safety
Levi & Korsinsky Notifies Shareholders of Replimune Group, Inc. (REPL) of a Class Action Lawsuit and an Upcoming Deadline
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Notifies Shareholders of Savara Inc. (SVRA) of a Class Action Lawsuit and an Upcoming Deadline
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers SVRA
Exposures Financial Legal Product Safety
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) Seeking Recovery for Investors Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
Shareholders That Lost Money on Cytokinetics, Incorporated (CYTK) Should Contact Levi &amp; Korsinsky About Pending Class Action - CYTK
Via TheNewswire.com
Topics Earnings Fraud Lawsuit
Tickers CYTK
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Notifies Shareholders of Replimune Group, Inc. (REPL) of a Class Action Lawsuit and an Upcoming Deadline
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) Seeking Recovery for Investors Contact Levi &amp; Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
No More Spreadsheets Two Childhood Friends Launch Card Codex – A Pokmon Card Database Built for Collectors
Via Binary News Network
Topics Product Recall
Exposures Legal Product Safety
Travel Dine Stay Announces Global Nomad Journey to 92 Countries
Via Press Release Distribution Service
Topics Product Recall Retirement
Exposures Legal Pension Product Safety
Select Motorz Offers Expert Tips for Thorough Used Car Inspections
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
Johnson & Johnson Confronts the End of its Talc Legacy with Multi-Billion Dollar Settlements
Via MarketMinute
Topics Bankruptcy Death Lawsuit
Tickers JNJ KVUE
Exposures Death Financial Legal
The Pharmaceutical Revolution: AI, Gene Therapies, and Obesity Drugs Reshape a Trillion-Dollar Market
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Tickers AMGN AZN CRSP EXAI LLY NTLA
Exposures Artificial Intelligence COVID-19 Intellectual Property
The Healthcare Horizon: Navigating Innovation, Policy Shifts, and Evolving Patient Care
Via MarketMinute
Topics Artificial Intelligence
Tickers DXCM GOOGL ILMN MSFT RHHBY TDOC
Exposures Artificial Intelligence Product Safety
Johnson & Johnson Unleashes Triple Threat: Bladder Cancer Breakthrough, Psoriasis Game-Changer, and Myasthenia Gravis Milestone Signal New Pharma Era
Via MarketMinute
Tickers ABBV ARGX AZN BMY JNJ LLY
Exposures Product Safety
Why Replimune Stock Was Tumbling Again Today
Via The Motley Fool
Tickers JPM REPL
Exposures Product Safety
Eli Lilly's Dual Triumph: Mounjaro Expands Reach, Orforglipron Set to Revolutionize Oral Diabetes and Weight Loss Market
Via MarketMinute
Tickers LLY NVO
Exposures Product Safety
Eli Lilly Poised for Blockbuster Q3 2025 with Skyrocketing EPS and Revenue Projections
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Tickers AMGN AZN LLY NVO PFE
Exposures Artificial Intelligence Intellectual Property Product Safety
Lilly's AI Gambit: TuneLab Poised to Reshape Biotech Drug Discovery Landscape
Via MarketMinute
Topics Animal Testing Artificial Intelligence Intellectual Property
Tickers LLY NVS PFE RXRX SDGR
Exposures Animal Testing Artificial Intelligence Intellectual Property
Lilly's Oncology Momentum Soars: Olomorasib Gains Breakthrough Status, Jaypirca Achieves Landmark Clinical Successes
Via MarketMinute
Tickers ABBV AMGN AZN BGNE BMY JNJ
Exposures Product Safety
MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Eyes Clear Development Pathway for AVERSA(TM) Technology
Via Investor Brand Network
Tickers NTRB
Exposures Product Safety
Integrative Health Miami Promotes Peptides for Recovery and Wellness
Via Press Advantage
Exposures Product Safety
Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why
Via StockStory
Tickers HIMS
Exposures Product Safety
Why DexCom (DXCM) Shares Are Trading Lower Today
Via StockStory
Tickers DXCM
Exposures Product Safety
Emergent BioSolutions Stock Rises After Receiving Fresh International Purchase Orders: Retail Says Stock Is ‘Significantly Undervalued’
Via Stocktwits
Tickers AVSU EBS IWMW
Exposures Product Safety
Medtronic's New Implant Could Transform Bladder Control Treatment
Via Benzinga
Tickers MDT
Exposures Product Safety
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today